NeoGenomics, Inc.

NEONASDAQ • USD
18.47 USD
↗ 0.69 (3.88%)AT CLOSE (03:59 PM EDT)
18.51
↗ 0.04 (0.20%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
18.51
↗ 0.04 (0.20%)
🔴Market: CLOSED

NeoGenomics, Inc. (NEO) is currently trading at $18.47. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, NEO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 2, 2026.

Open?$17.99
High?$18.69
Low?$17.94
Prev. Close?$17.78
Volume?2.3M
Avg. Volume?2.0M
VWAP?$18.40
Rel. Volume?1.13x
Bid / Ask
Bid?$15.88 × 100
Ask?$22.12 × 100
Spread?$6.24
Midpoint?$19.00
Valuation & Ratios
Market Cap?2.4B
Shares Out?128.5M
Float?125.9M
Float %?98.0%
P/E Ratio?N/A
P/B Ratio?3.02
EPS?-$0.40
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Employees
2.5K
Market Cap
2.4B
Industry
SERVICES-TESTING LABORATORIES
Listed
1996-01-25
Address
9490 NEOGENOMICS WAY
FORT MYERS, FL 33912
Phone: (239) 768-0600
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
95
Momentum?
88
Short Sent.?
43
Piotroski F-Score?4/9Mixed
Altman Z-Score?4.31Safe
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?13.27%High
Short Interest?16.7M
Days to Cover?11.2
Free Float125.9M
Avg Daily Volume1.5M
Settlement Date2026-09-15
Financial Health
Current Ratio?3.60Strong
Quick Ratio?3.35Strong
Cash Ratio?1.37Strong
Debt/Equity?0.48Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
56
3.02FAIR▾
P/S?
Peers
100
S&P
49
3.10FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
3
551.6HIGH▾
EV/Sales?
Peers
100
S&P
55
3.40FAIR▾
Returns & Efficiency
ROE?
S&P
10
-6.6%WEAK▾
ROA?
S&P
3
-3.8%WEAK▾
Cash Flow & Enterprise
FCF?$-7355000
Enterprise Value?$2.6B
Fundamentals ratios updated end of day